{"id":400,"date":"2021-10-13T16:59:22","date_gmt":"2021-10-13T14:59:22","guid":{"rendered":"https:\/\/acepartnerz.kinsta.cloud\/wanida\/?post_type=projet&p=400"},"modified":"2022-10-08T11:51:18","modified_gmt":"2022-10-08T09:51:18","slug":"etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide","status":"publish","type":"projet","link":"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/","title":{"rendered":"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide"},"content":{"rendered":"\n

Les tests s\u00e9rologiques sont con\u00e7us et valid\u00e9s \u00e0 des fins de surveillance et de recherche. Ce sont des tests qui recherchent la pr\u00e9sence d’anticorps, prot\u00e9ines sp\u00e9cifiques fabriqu\u00e9es en r\u00e9ponse \u00e0 des infections, en l’occurrence des virus SARS-CoV-2. L’enqu\u00eate de s\u00e9ropr\u00e9valence devrait estimer la pr\u00e9valence de l’infection et de l’exposition au SARS-CoV-2 dans une population et peut indiquer l’\u00e9tat immunitaire des individus ou des populations. <\/p>\n\n\n\n

Au Nigeria, peu d’enqu\u00eates de s\u00e9ropr\u00e9valence sur le SARS-CoV-2 ont \u00e9t\u00e9 men\u00e9es. Une \u00e9tude pilote dans l’\u00c9tat du Niger ne comptait que 85 participants. L’\u00e9tude a r\u00e9v\u00e9l\u00e9 un taux de positivit\u00e9 pour COVID 19 de 25,41 % et de 2,16 % pour les IgG et IgM positifs respectivement. La s\u00e9ropr\u00e9valence variait selon les groupes d’\u00e2ge, le sexe et la profession.<\/p>\n\n\n\n

Impacts de l’\u00e9tude :
<\/strong>Les r\u00e9sultats de cette \u00e9tude influenceront les d\u00e9cisions politiques du gouvernement, des partenaires internationaux de d\u00e9veloppement (IPS) et des organisations non gouvernementales dans la pr\u00e9vention et le contr\u00f4le du COVID 19 au Nigeria. Elle contribuera \u00e9galement \u00e0 l’ensemble des connaissances en g\u00e9n\u00e9rant des informations pr\u00e9cieuses sur l’\u00e9pid\u00e9miologie de COVID 19 pour une future \u00e9valuation du programme.<\/p>\n","protected":false},"excerpt":{"rendered":"

Les tests s\u00e9rologiques sont con\u00e7us et valid\u00e9s \u00e0 des fins de surveillance et de recherche. Ce sont des tests qui recherchent la pr\u00e9sence d’anticorps, prot\u00e9ines sp\u00e9cifiques fabriqu\u00e9es en r\u00e9ponse \u00e0 des infections, en l’occurrence des virus SARS-CoV-2. L’enqu\u00eate de s\u00e9ropr\u00e9valence devrait estimer la pr\u00e9valence de l’infection et de l’exposition au SARS-CoV-2 dans une population et […]<\/p>\n","protected":false},"featured_media":401,"menu_order":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"type-projet":[],"class_list":["post-400","projet","type-projet","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide - WANIDA<\/title>\n<meta name=\"description\" content=\"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide\" \/>\n<meta property=\"og:description\" content=\"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/\" \/>\n<meta property=\"og:site_name\" content=\"WANIDA\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-08T09:51:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ace-partner.org\/wanida\/wp-content\/uploads\/sites\/5\/2021\/10\/DSC_6176-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide\" \/>\n<meta name=\"twitter:description\" content=\"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/ace-partner.org\/wanida\/wp-content\/uploads\/sites\/5\/2021\/10\/DSC_6176-1.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/projet\\\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\\\/\",\"url\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/projet\\\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\\\/\",\"name\":\"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide - WANIDA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/projet\\\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/projet\\\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2021\\\/10\\\/DSC_6176-1.jpg\",\"datePublished\":\"2021-10-13T14:59:22+00:00\",\"dateModified\":\"2022-10-08T09:51:18+00:00\",\"description\":\"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/projet\\\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/projet\\\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/projet\\\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2021\\\/10\\\/DSC_6176-1.jpg\",\"contentUrl\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2021\\\/10\\\/DSC_6176-1.jpg\",\"width\":1500,\"height\":1000,\"caption\":\"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/projet\\\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/#website\",\"url\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/\",\"name\":\"WANIDA\",\"description\":\"R\u00e9seau Ouest Africain des centres d'excellence Africains sur les maladies infectieuses\",\"publisher\":{\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/#organization\",\"name\":\"WANIDA\",\"url\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2021\\\/08\\\/WANIDA.webp\",\"contentUrl\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2021\\\/08\\\/WANIDA.webp\",\"width\":141,\"height\":52,\"caption\":\"WANIDA\"},\"image\":{\"@id\":\"https:\\\/\\\/ace-partner.org\\\/wanida\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide - WANIDA","description":"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/","og_locale":"fr_FR","og_type":"article","og_title":"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide","og_description":"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide","og_url":"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/","og_site_name":"WANIDA","article_modified_time":"2022-10-08T09:51:18+00:00","og_image":[{"width":1500,"height":1000,"url":"https:\/\/ace-partner.org\/wanida\/wp-content\/uploads\/sites\/5\/2021\/10\/DSC_6176-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_title":"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide","twitter_description":"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide","twitter_image":"https:\/\/ace-partner.org\/wanida\/wp-content\/uploads\/sites\/5\/2021\/10\/DSC_6176-1.jpg","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/","url":"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/","name":"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide - WANIDA","isPartOf":{"@id":"https:\/\/ace-partner.org\/wanida\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/#primaryimage"},"image":{"@id":"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/#primaryimage"},"thumbnailUrl":"https:\/\/ace-partner.org\/wanida\/wp-content\/uploads\/sites\/5\/2021\/10\/DSC_6176-1.jpg","datePublished":"2021-10-13T14:59:22+00:00","dateModified":"2022-10-08T09:51:18+00:00","description":"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide","breadcrumb":{"@id":"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/#primaryimage","url":"https:\/\/ace-partner.org\/wanida\/wp-content\/uploads\/sites\/5\/2021\/10\/DSC_6176-1.jpg","contentUrl":"https:\/\/ace-partner.org\/wanida\/wp-content\/uploads\/sites\/5\/2021\/10\/DSC_6176-1.jpg","width":1500,"height":1000,"caption":"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide"},{"@type":"BreadcrumbList","@id":"https:\/\/ace-partner.org\/wanida\/projet\/etude-de-seroprevalence-du-sars-cov-2-dans-le-centre-nord-du-nigeria-par-test-de-diagnostic-rapide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ace-partner.org\/wanida\/"},{"@type":"ListItem","position":2,"name":"\u00c9tude de s\u00e9ropr\u00e9valence du SARS-CoV-2 par test de diagnostic rapide"}]},{"@type":"WebSite","@id":"https:\/\/ace-partner.org\/wanida\/#website","url":"https:\/\/ace-partner.org\/wanida\/","name":"WANIDA","description":"R\u00e9seau Ouest Africain des centres d'excellence Africains sur les maladies infectieuses","publisher":{"@id":"https:\/\/ace-partner.org\/wanida\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ace-partner.org\/wanida\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ace-partner.org\/wanida\/#organization","name":"WANIDA","url":"https:\/\/ace-partner.org\/wanida\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ace-partner.org\/wanida\/#\/schema\/logo\/image\/","url":"https:\/\/ace-partner.org\/wanida\/wp-content\/uploads\/sites\/5\/2021\/08\/WANIDA.webp","contentUrl":"https:\/\/ace-partner.org\/wanida\/wp-content\/uploads\/sites\/5\/2021\/08\/WANIDA.webp","width":141,"height":52,"caption":"WANIDA"},"image":{"@id":"https:\/\/ace-partner.org\/wanida\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/ace-partner.org\/wanida\/wp-json\/wp\/v2\/projet\/400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ace-partner.org\/wanida\/wp-json\/wp\/v2\/projet"}],"about":[{"href":"https:\/\/ace-partner.org\/wanida\/wp-json\/wp\/v2\/types\/projet"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ace-partner.org\/wanida\/wp-json\/wp\/v2\/media\/401"}],"wp:attachment":[{"href":"https:\/\/ace-partner.org\/wanida\/wp-json\/wp\/v2\/media?parent=400"}],"wp:term":[{"taxonomy":"type-projet","embeddable":true,"href":"https:\/\/ace-partner.org\/wanida\/wp-json\/wp\/v2\/type-projet?post=400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}